Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck

Natasha Honoré, Cédric van Marcke, Rachel Galot, Raphaël Helaers, Jérôme Ambroise, Aline van Maanen, Antonella Mendola, Hajar Dahou, Étienne Marbaix, P. Van Eeckhout, E. Longton, Michèle Magremanne, Sandra Schmitz, Nisha Limaye, J-P. Machiels